WATSON 408 (Lisinopril 20 mg)
Pill imprint WATSON 408 has been identified as Lisinopril 20 mg.
Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; alport syndrome; coronary artery disease (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WATSON 408
- Strength:
- 20 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0408
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
corn starch
FD&C Yellow No. 5
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63739-0350 | McKesson Packaging Services |
| 43063-0007 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about lisinopril
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
